Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chongqing Yuanda Pharmaceutical Research Center is the core research and development subsidiary of China Grand Pharmaceutical and Healthcare Holdings (Grandpharma). Based in Chongqing, China, the center focuses on the discovery, formulation development, and clinical advancement of chemical drugs, particularly in the respiratory and ENT (Ear, Nose, and Throat) therapeutic areas. It operates as a high-tech enterprise, managing a significant portion of the parent group's pipeline for inhaled and intranasal therapies. The center is equipped with advanced laboratories for chemical synthesis and quality control, supporting the group's transition toward innovative drug development. By integrating global resources, it plays a pivotal role in bringing high-end generics and novel combination therapies to the Chinese and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chongqing Yuanda Pharmaceutical Research Center.